anonymous
Guest
anonymous
Guest
Depomed aims to achieve its full-year guidance figures by replacing 25 percent of its underperforming reps. Analyst Irina Koffler expects the company to achieve the lower end of its guidance.
Read more: http://www.benzinga.com/analyst-ratings/analyst-color/16/05/7951006/mizuho-upgrades-depomed-on-increased-takeout-probability#ixzz4B1wA6fBS
Read more: http://www.benzinga.com/analyst-ratings/analyst-color/16/05/7951006/mizuho-upgrades-depomed-on-increased-takeout-probability#ixzz4B1wA6fBS